SB
| |
SAMSARA BIOCAPITAL, LLC13F | |
SAMSARA BIOCAPITAL, LLC | |
Last update 2025-05-15 | 37 Stocks (2 new) |
Value $561.00 Mil | Turnover 19 % |
SAMSARA BIOCAPITAL, LLC Top Holdings of 2025-03-31
View Full List
Ticker | | Company | Shares | Value ($1000) | Shares Change % | Weighting % | Trade Impact % | % of Shares outstanding | 3M Change % | YTD Change % | Market Cap $Mil | Industry |
---|---|---|---|---|---|---|---|---|---|---|---|---|
SRRK | Scholar Rock Holding Corp | 5,612,896 | 180,454.6 | 0% | 32.180 | 0% | 5.920 | +36.70% | -14.41% | 3,512.0 | Biotechnology | |
KLRS | Kalaris Therapeutics Inc | 11,448,081 | 91,928.1 | New Holding | 16.390 | +16.39% | 61.220 | -66.93% | 0% | 47.7 | Biotechnology | |
MLYS | Mineralys Therapeutics Inc | 5,674,916 | 90,117.7 | +11.82% | 16.070 | +1.70% | 8.710 | +12.00% | +16.73% | 936.6 | Biotechnology | |
NGNE | Neurogene Inc | 1,717,127 | 20,107.6 | 0% | 3.590 | 0% | 12.040 | +135.44% | -7.00% | 303.2 | Biotechnology | |
ALMS | Alumis Inc | 3,266,498 | 20,056.3 | 0% | 3.580 | 0% | 6.000 | -56.47% | -55.47% | 361.2 | Biotechnology | |
PVLA | Palvella Therapeutics Inc | 679,486 | 19,018.8 | 0% | 3.390 | 0% | 6.150 | +18.35% | +115.00% | 285.2 | Biotechnology | |
SEPN | Septerna Inc | 3,149,128 | 18,233.5 | +13.75% | 3.250 | +0.39% | 7.070 | +108.91% | -48.82% | 522.2 | Biotechnology | |
CRGX | Cargo Therapeutics Inc | 4,415,689 | 17,971.8 | 0% | 3.200 | 0% | 9.580 | +13.58% | -68.10% | 214.0 | Biotechnology | |
LENZ | LENZ Therapeutics Inc | 526,390 | 13,533.5 | -46.67% | 2.410 | -1.82% | 1.870 | +70.52% | +20.61% | 980.0 | Biotechnology | |
UPB | Upstream Bio Inc | 2,067,146 | 12,650.9 | -6.77% | 2.260 | -0.34% | 3.840 | +79.17% | -28.83% | 629.4 | Biotechnology |
SAMSARA BIOCAPITAL, LLC's Historical Top Holdings Breakdowns
SAMSARA BIOCAPITAL, LLC's Top Stock Picks
View Full List
Ticker | | Company | Date | Action | Impact % | Price Range | Price | Price Change from Avrg% | Comment | Current Shares | Share Change |
---|---|---|---|---|---|---|---|---|---|---|---|
KLRS | Kalaris Therapeutics Inc | 2025-03-31 | New Buy New Buy | +16.39% | 8.03 ($9.78) 11.47 | $2.55 | -73.93% | New holding | 11,448,081 | 11,448,081 | |
LENZ | LENZ Therapeutics Inc | 2025-03-31 | Reduce Reduce | -1.82% | 21.29 ($24.63) 28.46 | $34.82 | 41.37% | Reduce -46.67% | 526,390 | -460,591 | |
JSPR | Jasper Therapeutics Inc | 2025-03-31 | Sold Out Sold Out | -1.72% | 4.3 ($6.65) 21.09 | $3.68 | -44.66% | Sold Out | 0 | -584,642 | |
MLYS | Mineralys Therapeutics Inc | 2025-03-31 | Add Add | +1.70% | 8.76 ($11.5) 16.87 | $14.37 | 24.96% | Add 11.82% | 5,674,916 | 600,000 | |
ACLX | Arcellx Inc | 2025-03-31 | Reduce Reduce | -1.25% | 60.26 ($67.74) 79.13 | $69.00 | 1.86% | Reduce -46.67% | 135,276 | -118,365 | |
ACRS | Aclaris Therapeutics Inc | 2025-03-31 | Sold Out Sold Out | -0.81% | 1.53 ($2.13) 2.6 | $1.54 | -27.70% | Sold Out | 0 | -2,385,060 | |
ZYME | Zymeworks Inc | 2025-03-31 | Reduce Reduce | -0.67% | 11.1 ($13.64) 15.01 | $13.57 | -0.51% | Reduce -33.33% | 666,667 | -333,333 | |
CLYM | Climb Bio Inc | 2025-03-31 | Sold Out Sold Out | -0.64% | 1.22 ($1.62) 2.3 | $1.35 | -16.67% | Sold Out | 0 | -2,609,114 | |
VRNA | Verona Pharma PLC | 2025-03-31 | Sold Out Sold Out | -0.62% | 44.81 ($59.82) 69.63 | $104.77 | 75.14% | Sold Out | 0 | -97,625 | |
SRZN | Surrozen Inc | 2025-03-31 | New Buy New Buy | +0.50% | 9.7 ($11.62) 17.02 | $8.32 | -28.40% | New holding | 241,400 | 241,400 |
SAMSARA BIOCAPITAL, LLC Total Holding History ($B)
SAMSARA BIOCAPITAL, LLC's Asset Allocation
SAMSARA BIOCAPITAL, LLC Past Portfolios
Portfolio Date | Number of Stocks | New Stocks | Total Value ($Mil) | Q/Q Turnover |
---|---|---|---|---|
Top Ranked Articles
- 1
SAMSARA BIOCAPITAL, LLC's Hypothetical Growth since 2025-03-31
SAMSARA BIOCAPITAL, LLC's Yearly Returns
Year | Portfolio % | % | Excess Gain % |
---|
SAMSARA BIOCAPITAL, LLC's Holdings Heat Map
Size field:
SAMSARA BIOCAPITAL, LLC's Holdings Bubble Chart
SAMSARA BIOCAPITAL, LLC News
- 1